The association between prostate size and Gleason score upgrading depends on the number of biopsy cores obtained: Results from the Shared Equal Access Regional Cancer Hospital Database

BJU International

Volumn 102, Issue 9, 2008, Pages 1074-1079

  Turley, Ryan S ^a   Terris, Martha K ^b,c   Kane, Christopher J ^d   Aronson, William J ^e,f   Presti Jr , Joseph C ^g,h   Amling, Christopher L ⁱ   Freedland, Stephen J ^a,j,k  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h VA PALO ALTO HEALTH CARE SYSTEM   (United States)

ⁱ Alabama   (United States)

^j DURHAM VA MEDICAL CENTER   (United States)

^k DUKE UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

Biopsy cores; Prostate cancer; Prostate weight; Risk; Upgrading

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; BODY MASS; CANCER GRADING; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY;

BIOPSY, NEEDLE; DATABASES AS TOPIC; EPIDEMIOLOGIC METHODS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGAN SIZE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 53849102210     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08015.x     Document Type: Article

References (29)

1. Freedland SJ, Kane CJ, Amling CL, Aronson WJ, Terris MK, Presti JC Jr. Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications. Urology 2007 69 : 495 9
2. King CR, Long JP. Prostate biopsy grading errors: a sampling problem? Int J Cancer 2000 90 : 326 30
3. Sved PD, Gomez P, Manoharan M, Kim SS, Soloway MS. Limitations of biopsy Gleason grade: implications for counseling patients with biopsy Gleason score 6 prostate cancer. J Urol 2004 172 : 98 102
4. Gregori A, Vieweg J, Dahm P, Paulson DF. Comparison of ultrasound-guided biopsies and prostatectomy specimens: predictive accuracy of Gleason score and tumor site. Urol Int 2001 66 : 66 71
5. Garnett JE, Oyasu R, Grayhack JT. The accuracy of diagnostic biopsy specimens in predicting tumor grades by Gleason's classification of radical prostatectomy specimens. J Urol 1984 131 : 690 3
6. Turley RS, Hamilton RJ, Terris MK et al. Small transrectal ultrasound volume predicts clinically significant Gleason score upgrading after radical prostatectomy: results from the SEARCH database. J Urol 2008 179 : 523 7
7. Kulkarni GS, Al-Azab R, Lockwood G et al. Evidence for a biopsy derived grade artifact among larger prostate glands. J Urol 2006 175 : 505 9
8. Kassouf W, Nakanishi H, Ochiai A, Babaian KN, Troncoso P, Babaian RJ. Effect of prostate volume on tumor grade in patients undergoing radical prostatectomy in the era of extended prostatic biopsies. J Urol 2007 178 : 111 4
9. D'Amico AV, Renshaw AA, Arsenault L, Schultz D, Richie JP. Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapy. Int J Radiat Oncol Biol Phys 1999 45 : 841 6
10. King CR, McNeal JE, Gill H, Presti JC Jr. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. Int J Radiat Oncol Biol Phys 2004 59 : 386 91
11. Emiliozzi P, Maymone S, Paterno A et al. Increased accuracy of biopsy Gleason score obtained by extended needle biopsy. J Urol 2004 172 : 2224 6
12. Freedland SJ, Isaacs WB, Platz EA et al. Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study. J Clin Oncol 2005 23 : 7546 54
13. Hamilton RJ, Aronson WJ, Presti JC Jr. et al. Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database. Cancer 2007 110 : 2202 9
14. Lerner SE, Blute ML, Bergstralh EJ, Bostwick DG, Eickholt JT, Zincke H. Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy. J Urol 1996 156 : 137 43
15. Tollefson MK, Leibovich BC, Slezak JM, Zincke H, Blute ML. Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival. J Urol 2006 175 : 547 51
16. Freedland SJ, Amling CL, Dorey F et al. Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Urology 2002 60 : 670 4
17. Hall GS, Kramer CE, Epstein JI. Evaluation of radical prostatectomy specimens. A comparative analysis of sampling methods. Am J Surg Pathol 1992 16 : 315 24
18. Tewari A, Indudhara R, Shinohara K et al. Comparison of transrectal ultrasound prostatic volume estimation with magnetic resonance imaging volume estimation and surgical specimen weight in patients with benign prostatic hyperplasia. J Clin Ultrasound 1996 24 : 169 74
19. Sajadi KP, Terris MK, Hamilton RJ et al. Body mass index, prostate weight and transrectal ultrasound prostate volume accuracy. J Urol 2007 178 : 990 5
20. Marker PC, Donjacour AA, Dahiya R, Cunha GR. Hormonal, cellular, and molecular control of prostatic development. Dev Biol 2003 253 : 165 74
21. Imperato-McGinley J, Gautier T, Zirinsky K et al. Prostate visualization studies in males homozygous and heterozygous for 5 alpha-reductase deficiency. J Clin Endocrinol Metab 1992 75 : 1022 6
22. Imperato-McGinley J, Peterson RE. Male pseudohermaphroditism: the complexities of male phenotypic development. Am J Med 1976 61 : 251 72
23. Hammarsten J, Hogstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 2001 39 : 151 8
24. Partin AW, Oesterling JE, Epstein JI, Horton R, Walsh PC. Influence of age and endocrine factors on the volume of benign prostatic hyperplasia. J Urol 1991 145 : 405 9
25. Roberts RO, Bergstralh EJ, Cunningham JM et al. Androgen receptor gene polymorphisms and increased risk of urologic measures of benign prostatic hyperplasia. Am J Epidemiol 2004 159 : 269 76
26. Briganti A, Chun FK, Suardi N et al. Prostate volume and adverse prostate cancer features: fact not artifact. Eur J Cancer 2007 43 : 2669 77
27. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Tomaszewski JE, Wein A. A prostate gland volume of more than 75 cm3 predicts for a favorable outcome after radical prostatectomy for localized prostate cancer. Urology 1998 52 : 631 6
28. Foley CL, Bott SR, Thomas K, Parkinson MC, Kirby RS. A large prostate at radical retropubic prostatectomy does not adversely affect cancer control, continence or potency rates. BJU Int 2003 92 : 370 4
29. Horninger W, Rogatsch H, Reissigl A et al. Correlation between preoperative predictors and pathologic features in radical prostatectomy specimens in PSA-based screening. Prostate 1999 40 : 56 61